Clinical Trial Update: MGD013 Monotherapy and Combination With Brivanib Dose Escalation and Expansion Study in Advanced Liver Cancer Patients [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports termination of the MGD013 monotherapy and MGD013 with brivanib dose escalation/expansion study in advanced hepatocellular car…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Brivanib (brivanib)
• MGD013 (MGD013)

Snippet

Sponsor: Zai Lab (Shanghai) Co., Ltd. | Conditions: Advanced Hepatocellular Carcinoma (HCC) | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-07-23